Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
1138
-
Total 13F shares, excl. options
-
92.5M
-
Shares change
-
-381K
-
Total reported value, excl. options
-
$66.7B
-
Value change
-
-$270M
-
Put/Call ratio
-
1.31
-
Number of buys
-
440
-
Number of sells
-
-520
-
Price
-
$721.49
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2022
1,272 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.5M shares
of 105M outstanding shares and own 88.12% of the company stock.
Largest 10 shareholders include FMR LLC (11.1M shares), BlackRock Inc. (9.17M shares), VANGUARD GROUP INC (8.72M shares), Capital World Investors (6.24M shares), JPMORGAN CHASE & CO (6.11M shares), STATE STREET CORP (4.96M shares), WELLINGTON MANAGEMENT GROUP LLP (2.42M shares), Dodge & Cox (2.22M shares), GEODE CAPITAL MANAGEMENT, LLC (2.21M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.72M shares).
This table shows the top 1138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.